BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35965804)

  • 1. The expression landscape of FOXP3 and its prognostic value in breast cancer.
    Li J; Zhang X; Liu B; Shi C; Ma X; Ren S; Zhao X; Liu Y
    Ann Transl Med; 2022 Jul; 10(14):801. PubMed ID: 35965804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.
    Sun M; Tang C; Liu J; Jiang W; Yu H; Dong F; Huang C; Rixiati Y
    BMC Cancer; 2021 Jun; 21(1):696. PubMed ID: 34120621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NR3C2-Related Transcriptome Profile and Clinical Outcome in Invasive Breast Carcinoma.
    Lu J; Hu F; Zhou Y
    Biomed Res Int; 2021; 2021():9025481. PubMed ID: 33564687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of a novel zinc finger protein-related gene-based prognostic model for breast cancer.
    Ye M; Li L; Liu D; Wang Q; Zhang Y; Zhang J
    PeerJ; 2021; 9():e12276. PubMed ID: 34721975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mining the prognostic significance and immune infiltration of
    Zhou Y; Jiang S; Yu S; Zhu L; Liu Y; Li S; Hao N; Ren Y
    Gland Surg; 2022 Apr; 11(4):720-741. PubMed ID: 35531108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer.
    Li F; Sun H; Li Y; Bai X; Dong X; Zhao N; Meng J; Sun B; Zhang D
    BMC Cancer; 2021 Dec; 21(1):1305. PubMed ID: 34876062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer.
    Song C; Shang F; Tu W; Liu X
    BMC Cancer; 2023 Mar; 23(1):296. PubMed ID: 37004015
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Li Y; Li F; Bai X; Li Y; Ni C; Zhao X; Zhang D
    Front Oncol; 2021; 11():658547. PubMed ID: 34094951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma.
    Zhang D; Duan Y; Cun J; Yang Q
    Front Genet; 2019; 10():278. PubMed ID: 30984247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low KRT15 expression is associated with poor prognosis in patients with breast invasive carcinoma.
    Zhong P; Shu R; Wu H; Liu Z; Shen X; Hu Y
    Exp Ther Med; 2021 Apr; 21(4):305. PubMed ID: 33717248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer.
    Shen Y; Xue J; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
    World J Surg Oncol; 2022 Dec; 20(1):398. PubMed ID: 36517818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Ten-Gene Related to Lipid Metabolism for Predicting Overall Survival of Breast Invasive Carcinoma.
    Wang Z; Wang F
    Contrast Media Mol Imaging; 2022; 2022():8348780. PubMed ID: 35919504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatic analysis of the expression and prognosis of ZNF589 in human breast cancer.
    Fan J; Zhang Z; Chen D; Chen H; Yuan W; Zhou L; Xu J; Liu W; Xu Y
    Transl Cancer Res; 2021 May; 10(5):2286-2304. PubMed ID: 35116546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of caspase-1 (
    Peng J; Wei Q; Zhou S; Gu Z; Lv K
    Transl Cancer Res; 2023 Aug; 12(8):2138-2154. PubMed ID: 37701103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer.
    Fang Z; Song YX; Wo GQ; Zhou HL; Li L; Yang SY; Chen X; Zhang J; Tang JH
    Ann Transl Med; 2022 Dec; 10(23):1280. PubMed ID: 36618780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of the PTPN13 expression and its clinical implication in breast cancer.
    Li JP; Zhang XM; Liu BC; Ren SG; Zhao XH; Liu YJ
    Neoplasma; 2023 Apr; 70(2):188-198. PubMed ID: 36812232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
    Zhang Q; Xia T; Qi C; Du J; Ye C
    BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma.
    Ling J; Peng N; Luo L
    J Clin Lab Anal; 2022 Jun; 36(6):e24362. PubMed ID: 35373393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Validation of an m6A Modification of JAK-STAT Signaling Pathway-Related Prognostic Prediction Model in Gastric Cancer.
    Jiang F; Chen X; Shen Y; Shen X
    Front Genet; 2022; 13():891744. PubMed ID: 35928449
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhancer RNA SLIT2 Inhibits Bone Metastasis of Breast Cancer Through Regulating P38 MAPK/c-Fos Signaling Pathway.
    Li P; Lin Z; Liu Q; Chen S; Gao X; Guo W; Gong F; Wei J; Lin H
    Front Oncol; 2021; 11():743840. PubMed ID: 34722297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.